ACHIEVING ASDAS-CRP MAJOR IMPROVEMENT AND INACTIVE DISEASE IN PATIENTS WITH ANKYLOSING SPONDYLITIS AFTER TREATMENT WITH GOLIMUMAB IS ASSOCIATED WITH NORMALIZED HEALTH RELATED QUALITY OF LIFE: TWO-YEAR RESULTS FROM THE GO-RAISE TRIAL